Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
Bellmunt
J
J
Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain.
Orsola
A
A
Maldonado
X
X
Kataja
V
V
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D015653:Cystectomy; D003558:Cystoscopy; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008197:Lymph Node Excision; D015201:Meta-Analysis as Topic; D009361:Neoplasm Invasiveness / Q000175:diagnosis / Q000473:pathology; D009362:Neoplasm Metastasis / Q000628:therapy; D009367:Neoplasm Staging; D010166:Palliative Care; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*